neuropathy

(redirected from Neuropathic pain)
Also found in: Thesaurus, Medical, Encyclopedia.

neu·rop·a·thy

 (no͝o-rŏp′ə-thē, nyo͝o-)
n. pl. neu·rop·a·thies
Any of various diseases or abnormalities of the nervous system, especially of the peripheral nervous system.

neu′ro·path′ic (-rə-păth′ĭk) adj.

neuropathy

(njʊˈrɒpəθɪ)
n
(Pathology) disease of the nervous system
neuropathic adj
ˌneuroˈpathically adv

neu•rop•a•thy

(nʊˈrɒp ə θi, nyʊ-)

n.
any diseased condition of the nervous system.
[1855–60]
neu•ro•path•ic (ˌnʊər əˈpæθ ɪk, ˌnyʊər-) adj.
neu`ro•path′i•cal•ly, adv.

neuropathy

any disease or disorder of the nerves. — neuropathist, n. — neuropathie, adj.
See also: Nerves
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.neuropathy - any pathology of the peripheral nerves
pathology - any deviation from a healthy or normal condition
Charcot-Marie-Tooth disease, hereditary motor and sensory neuropathy - a form of neuropathy that can begin between childhood and young adulthood; characterized by weakness and atrophy of the muscles of the hands and lower legs; progression is slow and individuals affected can have a normal life span; inheritance is X-linked recessive or X-linked dominant
mononeuropathy - any neuropathy of a single nerve trunk
multiple mononeuropathy - pathology of several individual nerve trunks
Translations
hermosairausneuropatia

neuropathy

[njʊˈrɒpəθɪ] Nneuropatía f

neuropathy

[njʊˈrɒpəθɪ] nneuropatia

neu·rop·a·thy

n. neuropatía, trastorno o cambio patológico en los nervios periféricos;
autonomic ______ autónoma;
motor ______ motora.

neuropathy

n neuropatía f; diabetic — neuropatía diabética; peripheral — neuropatía periférica; sensory — neuropatía sensitiva or sensorial
References in periodicals archive ?
Food and Drug Administration approved multiple applications for first generics of Lyrica for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury, the agency announced today.
It comes in two forms: inflammatory pain and neuropathic pain.
PHILADELPHIA -- Nearly 7%-10% of the general population experiences neuropathic pain, but studies on treatments have not found a clear winner for reducing this "burning or electriclike pain," explained Raymond Price, MD, during a presentation.
2015 Feb; 14[2]:162-73) conducted that determined the number needed to treat for neuropathic pain treatments, Dr.
NEW HOPE: Doctors Dheeraj Gandhi, left, Chief of Interventional Neuroradiology, and Howard Eisenberg, Neurosurgery, University of Maryland Medical Center, are using targeted ultrasound to treat neuropathic pain in a clinical trial.
ligand1 , created by Daiichi Sankyo, was approved for marketing in Japan in January 2019 on the basis of the results of phase 3 clinical trials conducted in Asia including Japan in patients with diabetic peripheral neuropathic pain (DPNP) 2 and postherpetic neuralgia (PHN) 3, for the indication of peripheral neuropathic pain (PNP) 4.
M2 PHARMA-January 10, 2019-NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain
In Europe, it is approved for a broad peripheral neuropathic pain indication in adults, e.g.
(1) One of the most severe forms of chronic pain is neuropathic pain, which results from damage to the central or peripheral nervous systems.
Objective: To determine the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in management of neuropathic pain in post-traumatic incomplete spinal cord injury patients.
The global neuropathic pain management market is expected to be worth US$ 10,414.0 Mn in 2026, it is projected to increase at a CAGR of 5.6% through 2026.
[ClickPress, Tue Oct 09 2018] According to the latest market report published by Persistence Market Research titled 'Global Market Study on Neuropathic Pain Management: Tricyclic Antidepressants Drug Class Segment Projected to Witness the Highest Growth Through 2026', the global neuropathic pain management market is projected to expand at a CAGR of 5.6% during an eight-year forecast period 2018--2026 and reach US$ 10.4 Bn by the end of 2026.